Mohnarin 2009 Report:Bacterial Drug Resistant Surveillance of Non-Icu Inpatients

GAO Lei,LV Yuan
DOI: https://doi.org/10.3969/j.issn.1001-6821.2011.05.008
2011-01-01
Abstract:Objective To investigate the antibacterial drug resistance of clinical isolates from non-ICU inpatients in China.Methods Clinical isolates were collected by 114 member hospitals of Mohnarin according to the unified protocol.Drug sensitivity test was carried out by using Kirby-Bauer(K-B),MIC or E-test methods according to CLSI 2008.The data were analyzed by WHONET 5.5 software.Results A total of 108946 clinical isolates from inpatients of non-ICU department in Mohnarin member hospitals were collected from Jan to Dec 2008.Methicillin-resistant strains in Staphlococcus aureus(MRSA) and coagulase-negative Staphylococcus(MRCoN) accounted for 54.3% and about 80%,respectively.E.faecalis and E.faecium isolates were 0.7% and 3.3% resistant to vancomycin,respectively.The detected rates of ESBL-producing E.coli and K.pneumoniae were 65.5% and 45.0%,respectively.Enterobacteriaceae isolates were still highly sensitive to imipenem and meropenem,the resistant rate was less than 2%,and more than 60% of E.coli isolates resistant to quinolones.The drug resistance rates of non-fermented bacteria to meropenem were 20%-45%,and the drug resistance rate of Acinetobacter baumannii was higher than that of P.aeruginosa.Conclusion Enterobacteriaceae and Staphylococci are the predominant pathogens in non-ICU inpatients.Bacterial drug resistance is severe.
What problem does this paper attempt to address?